Research
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
-
* Corresponding author: Marya D Zilberberg mzilberb@schoolph.umass.edu
Critical Care 2009, 13:R94 doi:10.1186/cc7924
See related commentary by Golan, http://ccforum.com/content/13/4/180
No comments have yet been made on this article.